We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Ask ADVFN Intelligence (AI)
Cox Automotive Inc., the owner of brands such as Kelley Blue Book, said Monday that it has agreed to buy Dealertrack Technologies Inc. for about $3.5 billion in a move to broaden its services for...
By Shalini Ramachandran An investment banking adviser close to Time Warner Cable Inc. reached out to Cox Communications Inc. in recent days to discuss the possibility of a combination of the two...
SOPHIA ANTIPOLIS, France, April 17, 2015 (GLOBE NEWSWIRE) -- Nicox S.A. (Euronext Paris: FR0000074130, COX), the international ophthalmic company, today reported its first quarter 2015 revenues...
A year of strategic progress: Positive phase 3 results for Vesneo(TM) (Bausch + Lomb); NDA submission on track for Q2 2015 Significant strengthening of ophthalmic therapeutics...
SOPHIA ANTIPOLIS, France, March 19, 2015 (GLOBE NEWSWIRE) -- Nicox S.A. (Euronext Paris: COX) today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug...
InSite grants Nicox exclusive license for AzaSite® (1% azithromycin), BromSite(TM) (0.075% bromfenac) and AzaSite Xtra(TM) (2% azithromycin) in Europe, Middle East and...
SOPHIA ANTIPOLIS, France, Jan. 26, 2015 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, today announced that it has held a positive pre-New Drug...
Nicox gains expanded North American rights for Sjö(TM) from Immco Diagnostics Nicox acquires extension of rights to market Sjö(TM) to all healthcare practitioners in North...
Nicox to focus US marketing resources on national roll-out of Sjö(TM) and launch of RetnaGene(TM) Rapid Pathogen Screening (RPS®) partnership for AdenoPlus® and two other...
Significant step forward in Nicox's strategy of creating an international ophthalmic company built around therapeutics and diagnostics Aciex brings a near-term pipeline of ophthalmic...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
